<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wu C</submitter><funding>Beijing Xisike Clinical Oncology Research Foundation</funding><funding>National Natural Science Foundation of China</funding><funding>Peking University Third Hospital</funding><funding>National Clinical Key Specialty Construction Program, P. R. China</funding><pagination>5829-5840</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12672776</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>104(11)</volume><pubmed_abstract>Diffuse large B-cell lymphoma (DLBCL) is a highly aggressive form of non-Hodgkin lymphoma. B symptoms, including fever, night sweats and weight loss, are often overlooked but carry prognostic significance. The primary site of DLBCL also plays a crucial role in diagnosis and treatment decisions, and our study aims to explore the relationship among primary sites of DLBCL, the presence of B symptoms and patients' survival. 15,267 patients' data were analyzed in our study to investigate the potential relevance among B symptoms, primary sites and patients' survival. We assessed the influence of primary site and B symptoms on survival with the use of Survival package and Kaplan-Meier survival analysis. Age, race and Ann-Arbor stage were significantly associated with the presence of B symptoms. T</pubmed_abstract><journal>Annals of hematology</journal><pubmed_title>A comprehensive analysis of B symptoms reveals prognosis and heterogeneity across different sites of diffuse large B-cell lymphoma.</pubmed_title><pmcid>PMC12672776</pmcid><funding_grant_id>BYSYZD2019026</funding_grant_id><funding_grant_id>81800195</funding_grant_id><funding_grant_id>Y-NCJH202201-0049</funding_grant_id><pubmed_authors>Wu C</pubmed_authors><pubmed_authors>Qi W</pubmed_authors><pubmed_authors>Hao X</pubmed_authors><pubmed_authors>Chen C</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Yang F</pubmed_authors><pubmed_authors>Li M</pubmed_authors><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Zhang W</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Zhu M</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Xiao J</pubmed_authors><pubmed_authors>Yang P</pubmed_authors><pubmed_authors>Wu S</pubmed_authors><pubmed_authors>Bao F</pubmed_authors><pubmed_authors>Yan C</pubmed_authors><pubmed_authors>Yuan X</pubmed_authors><pubmed_authors>Yu Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>A comprehensive analysis of B symptoms reveals prognosis and heterogeneity across different sites of diffuse large B-cell lymphoma.</name><description>Diffuse large B-cell lymphoma (DLBCL) is a highly aggressive form of non-Hodgkin lymphoma. B symptoms, including fever, night sweats and weight loss, are often overlooked but carry prognostic significance. The primary site of DLBCL also plays a crucial role in diagnosis and treatment decisions, and our study aims to explore the relationship among primary sites of DLBCL, the presence of B symptoms and patients' survival. 15,267 patients' data were analyzed in our study to investigate the potential relevance among B symptoms, primary sites and patients' survival. We assessed the influence of primary site and B symptoms on survival with the use of Survival package and Kaplan-Meier survival analysis. Age, race and Ann-Arbor stage were significantly associated with the presence of B symptoms. T</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-05T22:15:06.283Z</modification><creation>2026-05-22T03:15:44.946Z</creation></dates><accession>S-EPMC12672776</accession><cross_references><pubmed>41071290</pubmed><doi>10.1007/s00277-025-06579-5</doi></cross_references></HashMap>